Predictive Oncology Inc.’s filing revealed that its Director HANDLEY DANIEL E acquired Company’s shares for reported $955.0 on May 26. In the deal valued at $0.37 per share,2,550 shares were bought. As a result of this transaction, HANDLEY DANIEL E now holds 49,666 shares worth roughly $ 19866.4.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Then, HANDLEY DANIEL E bought 2,800 shares, generating $980 in total proceeds. Upon buying the shares at $0.35, the Director now owns 47,116 shares.
Before that, ENGLE J MELVILLE bought 159,500 shares. Predictive Oncology Inc. shares valued at $59,334 were divested by the Director at a price of $0.37 per share. As a result of the transaction, ENGLE J MELVILLE now holds 203,393 shares, worth roughly $81357.20000000001.
Price Performance Review of POAI
On Tuesday, Predictive Oncology Inc. [NASDAQ:POAI] saw its stock jump 19.07% to $0.40. On the same session, the stock had its day’s lowest price of $0.3901, but rose to a high of $0.415. Over the last five days, the stock has gained 6.43%. Predictive Oncology Inc. shares have fallen nearly -58.28% since the year began. Nevertheless, the stocks have fallen -61.07% over the past one year. While a 52-week high of $1.47 was reached on 03/25/22, a 52-week low of $0.25 was recorded on 05/20/22. SMA at 50 days reached $0.5586, while 200 days put it at $0.9015. A total of 0.87 million shares were traded, compared to the trading of 0.18 million shares in the previous session.
Levels Of Support And Resistance For POAI Stock
The 24-hour chart illustrates a support level at 0.3865, which if violated will result in even more drops to 0.3758. On the upside, there is a resistance level at 0.4114. A further resistance level may holdings at 0.4256. The Relative Strength Index (RSI) on the 14-day chart is 44.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0264, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.80%. Stochastics %K at 31.55% indicates the stock is a holding.
How much short interest is there in Predictive Oncology Inc.?
A steep rise in short interest was recorded in Predictive Oncology Inc. stocks on Apr 28, 2022, dropping by -0.21 million shares to a total of 0.73 million shares. Yahoo Finance data shows the prior-month short interest on Mar 30, 2022 was 0.94 million shares. There was a decline of -28.68%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.15% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.82.
Predictive Oncology Inc. [POAI] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 2,098,158 shares, or roughly 3.17% of the outstanding POAI shares. In other words, the investor’s shares have fallen by 0 from its previous 13-F filing of 2098158.0. Additionally, Geode Capital Management LLC increased 3.67% of its stake after which the total value it holdings stand at $234,626, while SSgA Funds Management, Inc. added 3.16% of its stake to hold $89572.0 in the firm. Over the last quarter, T. Rowe Price Associates, Inc. sold 0 shares of Predictive Oncology Inc., while Carnegie Mellon University sold 0 shares. At present, BlackRock Fund Advisors is holding 149,894 shares valued at $54861.0. Northern Trust Investments, Inc. owned 90,253 shares of the company at the time of its most recent 13F filing, worth $33033.0.
According to FactSet, Predictive Oncology Inc.’s share price will average $5.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 1415.15 percent from its previous closing price of $0.33. Analysts expect Predictive Oncology Inc. stock to reach the higher price of $5.00, while the lowest price estimate is $5.00. However, 2 analysts have rated POAI stock as a Buy in their predictions for 2022.